Correlation of total body photography frequency and invasive melanoma depth - 11/02/20
Doi : 10.1016/j.jaad.2019.11.003
Elizabeth D. Drugge, PhD, MPH a, ⁎ 
, Rebecca M. Sarac, MD b, Dirk M. Elston, MD c, Rhett J. Drugge, MD d
, Rebecca M. Sarac, MD b, Dirk M. Elston, MD c, Rhett J. Drugge, MD d a New York Medical College, Valhalla, New York
b Mount Sinai Beth Israel, New York, New York
c Medical University of South Carolina, Charleston
d Sheard & Drugge, PC, Stamford, Connecticut
∗Reprint requests: Elizabeth D. Drugge, PhD, MPH, New York Medical College, School of Health Sciences & Institute of Public Health, Epidemiology Division, 40 Sunshine Cottage Road, Valhalla, NY 10595.New York Medical CollegeSchool of Health Sciences & Institute of Public HealthEpidemiology Division40 Sunshine Cottage RoadValhallaNY10595
Abbreviation used : TBP
| Funding sources: None. |
|
| Disclosure: Dr Rhett Drugge is the inventor and holder of the intellectual property rights (US patent 7 359 748) of the Melanoscan system. Dr Elizabeth Drugge is a first-degree relative of Dr Rhett Drugge. Drs Sarac and Elston have no conflicts of interest to declare. |
|
| IRB approval status: Reviewed and approved by Phelps County Regional Medical Center #00002052 (Assurance 00002052). |
© 2019
Publié par Elsevier Masson SAS.
Vol 82 - N° 3
P. 768-769 - mars 2020 Retour au numéro
Article précédent
- Assessing perceived adverse effects of biologic medications for patients with psoriasis
- Jeremy K. Bray, Abigail Cline, Steven R. Feldman
- Vitiligo under anti–programmed cell death-1 therapy is associated with increased survival in melanoma patients
- Charlée Nardin, Anne Jeand'heur, Kévin Bouiller, Marie Blanche Valnet-Rabier, Flora Dresco, Julie Castagna, Adrien Mareschal, Clémentine Carlet, Virginie Nerich, Samuel Limat, Eve Puzenat, François Aubin
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?